Detailed answers about DRAKE MEDICAL WRITING & CONSULTANCY LIMITED, including incorporation, status, business activity, and accounts information.
When was DRAKE MEDICAL WRITING & CONSULTANCY LIMITED founded?
DRAKE MEDICAL WRITING & CONSULTANCY LIMITED was officially incorporated on 2 October 2023 and is registered under company number 15180745. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DRAKE MEDICAL WRITING & CONSULTANCY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DRAKE MEDICAL WRITING & CONSULTANCY LIMITED?
DRAKE MEDICAL WRITING & CONSULTANCY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DRAKE MEDICAL WRITING & CONSULTANCY LIMITED do?
DRAKE MEDICAL WRITING & CONSULTANCY LIMITED operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is DRAKE MEDICAL WRITING & CONSULTANCY LIMITED's registered address?
The registered office address of DRAKE MEDICAL WRITING & CONSULTANCY LIMITED is GREETWELL PLACE, 2 LIME KILN WAY, LINCOLN, ENGLAND, LN2 4US. This is the official address filed with Companies House for legal and statutory correspondence.
Is DRAKE MEDICAL WRITING & CONSULTANCY LIMITED financially stable?
The most recent accounts for DRAKE MEDICAL WRITING & CONSULTANCY LIMITED were made up to 31 October 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 July 2026.